HGT-HIT-094: A Controlled, Randomized, Two-arm, Open-label, Assessor-blinded, Multicenter Study of Intrathecal Idursulfase-IT Administered in Conjunction with Elaprase® in Pediatric Patients with Hunter Syndrome and Early Cogni

Project: Research project

Project Details

StatusFinished
Effective start/end date4/21/14 → 10/9/18

Funding

  • Shire Human Genetic Therapies, Inc.